Omega Healthcare Reports $0.27 EPS, $0.82 AFFO per Share and Raises 2026 Guidance
Omega Healthcare reported Q3 2026 earnings of $0.27 per share and $0.82 AFFO per share, with revenue up to $340.6M from $311.6M YoY. The company raised its full-year AFFO guidance to $3.28–$3.30 per share. Omega completed new investments and saw improvements in operator metrics, including 82.7% occupancy.
How this was made

The 30-second read
Why it matters
The key tradable catalyst is the raised 2026 Adjusted FFO guidance range, alongside improved occupancy and coverage metrics, which together affect forward cash-flow expectations for the REIT.
Market read
A raised 2026 AFFO outlook with operational improvements is likely to be the primary driver for positioning in OHI and peer REITs focused on senior housing and skilled nursing.
What to watch
Genesis bankruptcy sale mechanics (lease assumption/assignment and loan repayments) could carry integration or tenant-risk nuances not fully captured by headline AFFO guidance.
Background
Omega Healthcare Investors reported Q3 2026 results and described ongoing investment activity, including U.S. senior housing/skilled nursing acquisitions and U.K. care home lease-structure shifts.
Ticker impact
Omega Healthcare raised full-year 2026 Adjusted FFO guidance to $3.28–$3.30 per diluted share after reporting Q3 results and improved operator metrics.
Likely upward bias as the market reprices 2026 AFFO/cash-flow outlook following the guidance increase.
The article is a primary earnings/guidance disclosure with specific raised AFFO range and operational improvements (occupancy and coverage), which typically drives REIT earnings power expectations.
Market effects
Supports sentiment for senior housing/skilled nursing REITs by signaling improved occupancy and lease-structure transitions (PACS/RIDEA) translating into better coverage.
Limited direct regional read-through beyond U.S. skilled nursing and U.K. care home operations.
Low; primarily company-specific within healthcare real estate.
Counterpoint
The guidance raise may already be partially anticipated; investors may focus on whether occupancy and coverage gains are sustainable versus driven by one-time lease transitions and bankruptcy-related assumptions.
Key entities
- companyOmega Healthcare Investors Inc
Reported Q3 2026 net income and Adjusted FFO, raised full-year 2026 Adjusted FFO guidance, and highlighted lease-structure transitions and improved operator metrics.
- transactionGenesis bankruptcy sale
Finalized sale where Omega’s master lease was assumed and assigned to the buyer, and related loans were repaid.


